The Changing View of Immunopathology in MS Treatment Presented by: Edward J. Fox, MD, PhD. By: TheFranceFoundation … Continue reading →

Principles of MS Treatment Presented by: Bruce Cree, MD, PhD. By: TheFranceFoundation … Continue reading →

By Levi Ismail Published: Saturday, May 18, 2013, 7:12 pm Related Content MASON CITY, IA -Its an opportunity to raise awareness for a disease many of us are still learning about. Walk MS brings together people of all walks of life for the common goal of curing the nervous system disease. For organizers, the main goal is to raise the $22,000 for research of a cure, but others say, supporting those affected by MS can make all the difference in finding a cure. An event like this makes people go What are all those folks in the orange shirts walking for? Oh, its the MS walk, what is MS? It just kind of raises it up to the forefront of discussion on what MS is and lets people understand the symptoms. Also, how people are afflicted with multiple sclerosis, said Joe Malone of Mason City. The walk which began at North Iowa Community College, spanned two miles and gave an opportunity for participants to meet and greet others affected by the disease. Since beginning the fundraiser back in 1988, the Walk MS event has earned more than $10 million dollars to help support people living with MS. For Joe, while … Continue reading →

Public release date: 17-May-2013 [ | E-mail | Share ] Contact: Charles Casey charles.casey@ucdmc.ucdavis.edu 916-734-9048 University of California - Davis Health System (SACRAMENTO, Calif.) Working with lab mice models of multiple sclerosis (MS), UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved medications against MS. The findings of the research study, published online today in the journal EMBO Molecular Medicine could have therapeutic applications for MS as well as cerebral palsy and leukodystrophies, all disorders associated with loss of white matter, which is the brain tissue that carries information between nerve cells in the brain and the spinal cord. The target, a protein referred to as mitochondrial translocator protein (TSPO), had been previously identified but not linked to MS, an autoimmune disease that strips the protective fatty coating off nerve fibers of the brain and spinal cord. The mitrochronical TSPO is located on the outer surface of mitochondria, cellular structures that supply energy to the cells. Damage to the fatty coating, or myelin, slows the transmission of the nerve signals that enable body movement as well as sensory and cognitive functioning. The scientists identified mitochondrial … Continue reading →

May 17, 2013 Working with lab mice models of multiple sclerosis (MS), UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved medications against MS. The findings of the research study, published online today in the journal EMBO Molecular Medicine could have therapeutic applications for MS as well as cerebral palsy and leukodystrophies, all disorders associated with loss of white matter, which is the brain tissue that carries information between nerve cells in the brain and the spinal cord. The target, a protein referred to as mitochondrial translocator protein (TSPO), had been previously identified but not linked to MS, an autoimmune disease that strips the protective fatty coating off nerve fibers of the brain and spinal cord. The mitrochronical TSPO is located on the outer surface of mitochondria, cellular structures that supply energy to the cells. Damage to the fatty coating, or myelin, slows the transmission of the nerve signals that enable body movement as well as sensory and cognitive functioning. The scientists identified mitochondrial TSPO as a potential therapeutic target when mice that had symptoms of MS improved after being treated with the anti-anxiety drug … Continue reading →